| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |